<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="List of phenodata per study. There are 3 studies with 4 branches:
s1
melanoma (nivolumab, phase1)

s2
RCC (nivolumab, phase1)

s3_nivo
RCC (nivolumab, phase3)

s3_ever
RCC (everolimus, phase3)


Each of the four list elements contains a data frame with samples as rows and
pheno-information as columns."><title>Li 2019 phenodata — li2019_pheno • dataMelanoma</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Li 2019 phenodata — li2019_pheno"><meta property="og:description" content="List of phenodata per study. There are 3 studies with 4 branches:
s1
melanoma (nivolumab, phase1)

s2
RCC (nivolumab, phase1)

s3_nivo
RCC (nivolumab, phase3)

s3_ever
RCC (everolimus, phase3)


Each of the four list elements contains a data frame with samples as rows and
pheno-information as columns."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">dataMelanoma</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.7</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"><li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/ggrlab/dataMelanoma/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Li 2019 phenodata</h1>
      <small class="dont-index">Source: <a href="https://github.com/ggrlab/dataMelanoma/blob/HEAD/R/data_li2019.R" class="external-link"><code>R/data_li2019.R</code></a></small>
      <div class="d-none name"><code>li2019_pheno.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>List of phenodata per study. There are 3 studies with 4 branches:</p><dl><dt>s1</dt>
<dd><p>melanoma (nivolumab, phase1)</p></dd>

<dt>s2</dt>
<dd><p>RCC (nivolumab, phase1)</p></dd>

<dt>s3_nivo</dt>
<dd><p>RCC (nivolumab, phase3)</p></dd>

<dt>s3_ever</dt>
<dd><p>RCC (everolimus, phase3)</p></dd>


</dl><p>Each of the four list elements contains a data frame with samples as rows and
pheno-information as columns.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">li2019_pheno</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    <p>A list of 4 with a single tibble each.</p><dl><dt>s1</dt>
<dd><p>78 samples, 8 columns</p></dd>

<dt>s2</dt>
<dd><p>91 samples, 8 columns</p></dd>

<dt>s3_nivo</dt>
<dd><p>394 samples, 10 columns</p></dd>

<dt>s3_ever</dt>
<dd><p>349 samples, 10 columns</p></dd>


</dl><p>The data.frames <code>s1</code> and <code>s2</code> have the following columns:</p><dl><dt><code>Unique_Subject_Identifier</code></dt>
<dd><p>Identifier</p></dd>

<dt><code>Region</code></dt>
<dd><p>Sample region</p></dd>

<dt><code>Derived_Age_at_Consent</code></dt>
<dd><p>Age at consent</p></dd>

<dt><code>Sex</code></dt>
<dd><p>Sex. "M", "F".</p></dd>

<dt><code>Race</code></dt>
<dd><p>"WHITE" or "OTHER"</p></dd>

<dt><code>BRAF_V600E</code></dt>
<dd><p>BRAF_V600E mutation status</p></dd>

<dt><code>OS</code></dt>
<dd><p>Overall survival time</p></dd>

<dt><code>OS_Censor</code></dt>
<dd><p>Overall survival status</p></dd>


</dl><p>The data.frames <code>s3_nivo</code> and <code>s3_ever</code> have the following columns:</p><dl><dt><code>Unique_Subject_Identifier</code></dt>
<dd><p>Identifier</p></dd>

<dt><code>Treatment</code></dt>
<dd><p>"NIVOLUMAB" or "EVEROLIMUS"</p></dd>

<dt><code>Region</code></dt>
<dd><p>Sample region</p></dd>

<dt><code>Sex</code></dt>
<dd><p>"M" or "F"</p></dd>

<dt><code>Derived_Age_at_Consent</code></dt>
<dd><p>Age at consent</p></dd>

<dt><code>Race</code></dt>
<dd><p>"WHITE" or "OTHER"</p></dd>

<dt><code>CRF_MSKCC_Risk_Group</code></dt>
<dd><p>"FAVORABLE", "INTERMEDIATE" or "POOR"</p></dd>

<dt><code>Prior antiangiogenic regimens (≥2)</code></dt>
<dd></dd>

<dt><code>OS</code></dt>
<dd><p>Overall survival time</p></dd>

<dt><code>OS_Censor</code></dt>
<dd><p>Overall survival status</p></dd>


</dl></div>
    <div class="section level2">
    <h2 id="source">Source<a class="anchor" aria-label="anchor" href="#source"></a></h2>
    <p>Liu, D., Schilling, B., Liu, D. et al. Integrative molecular and clinical modeling of
clinical outcomes to PD1 blockade in patients with metastatic melanoma.
Nat Med 25, 1916–1927 (2019). https://doi.org/10.1038/s41591-019-0654-5</p>
    </div>

  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Gunther Glehr.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer></div>

  

  

  </body></html>

